Synergy Pharmaceuticals (United States)
- Research works
- 66 ▼ 19% vs 2013–17
- Citations
- 1.3k 20.3 per fractional work
- Top-10% rate
- 5.1% record average 16.5%
- Open access
- 26% world 28%
Not ranked overall: Synergy Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Decision Sciences, 3.6×. Every wedge is a field page.
- Decision Sciences 3.6×
- Pharmacology, Toxicology and Pharmaceutics 2.2×
- Medicine 2.1×
- Engineering 2.0×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Neuroscience 1.4×
- Economics, Econometrics and Finance 1.1×
- Immunology and Microbiology 1.0×
- Agricultural and Biological Sciences 0.8×
- Psychology 0.8×
- Business, Management and Accounting 0.7×
- Social Sciences 0.3×
Which keywords describe research at Synergy Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Enteric Nervous System, Intestinal Permeability, Probiotics, Gastrointestinal Disorders, Irritable Bowel Syndrome, Cancer and Cancer Therapy.
- Soft Systems Methodology
- Decision Making
- Pathogenicity
- Green Tea
- Escherichia coli
- Medicinal Plants
- Weight Loss
- TREM-1
- Hepatoprotective
- Endocan
- Herbal Medicine
- Genetics
- Neuroprotection
- Obesity
- Immune Response
- Metabolism
- Cancer Therapy
- Irritable Bowel Syndrome
- Probiotics
- Enteric Nervous System
- Inflammation
- Intestinal Permeability
- Gastrointestinal Disorders
- Cancer
- Antioxidant
- Neurological Disorders
- Antioxidant Activity
- Pathogenesis
- Cancer Prevention
- Genomic Analysis
- Sepsis
- Endothelial Cells
- Pharmacology
- Tumor Microenvironment
- Antibiotic Resistance
- Cardiovascular Health
- Gastric Cancer
- Helicobacter pylori
- Tea Polyphenols
- Bone Regeneration
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation12▲ 8.1×17 topics
- Enteric Nervous System6▲ 210×2 topics
- Intestinal Permeability6▲ 182×2 topics
- Probiotics6▲ 36×2 topics
- Gastrointestinal Disorders6▲ 145×1 topic
- Irritable Bowel Syndrome6▲ 254×1 topic
- Cancer4▲ 4.0×15 topics
- Cancer Therapy3▲ 6.5×9 topics
- Antioxidant3▲ 5.9×6 topics
- Metabolism2▲ 5.9×6 topics
- Neurological Disorders2▲ 5.6×7 topics
- Immune Response2▲ 5.4×6 topics
- Antioxidant Activity2▲ 5.6×7 topics
- Obesity2▲ 4.0×5 topics
- Pathogenesis2▲ 5.3×3 topics
- Neuroprotection2▲ 7.8×4 topics
- Cancer Prevention2▲ 11×3 topics
- Genetics2▲ 3.3×4 topics
- Genomic Analysis2▲ 7.8×3 topics
- Herbal Medicine2▲ 10×3 topics
- Sepsis2▲ 15×2 topics
- Endocan1▲ 272×1 topic
- Endothelial Cells1▲ 101×2 topics
- Hepatoprotective1▲ 26×2 topics
- Pharmacology1▲ 6.3×5 topics
- TREM-11▲ 272×1 topic
- Tumor Microenvironment1▲ 6.2×4 topics
- Weight Loss1▲ 13×3 topics
- Antibiotic Resistance1▲ 5.0×3 topics
- Medicinal Plants1▲ 5.5×8 topics
- Cardiovascular Health1▲ 9.6×2 topics
- Escherichia coli1▲ 79×1 topic
- Gastric Cancer1▲ 14×1 topic
- Green Tea1▲ 98×1 topic
- Helicobacter pylori1▲ 36×1 topic
- Pathogenicity1▲ 20×1 topic
- Tea Polyphenols1▲ 98×1 topic
- Decision Making1▲ 7.5×2 topics
- Bone Regeneration1▲ 14×2 topics
- Soft Systems Methodology1▲ 44×1 topic
Which research topics does Synergy Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Robotics and Automated Systems, Robot Manipulation and Learning, Acute Lymphoblastic Leukemia research and Teleoperation and Haptic Systems.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Robotics and Automated Systems Control and Systems Engineering 1 works
- 2 Robot Manipulation and Learning Control and Systems Engineering 0 works
- 3 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
- 4 Teleoperation and Haptic Systems Mechanical Engineering 0 works
- 5 Transgenic Plants and Applications Biotechnology 0 works
- 6 Smart Agriculture and AI Plant Science 0 works
- 7 CAR-T cell therapy research Oncology 0 works
- 8 Amyotrophic Lateral Sclerosis Research Neurology 0 works
- 9 Acute Myeloid Leukemia Research Hematology 0 works
- 10 Meta-analysis and systematic reviews Statistics, Probability and Uncertainty 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Synergy Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 19% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in New York
- Columbia University
- New York University
- Icahn School of Medicine at Mount Sinai
- Memorial Sloan Kettering Cancer Center
- City University of New York
- Human Growth Foundation
- Columbia University Irving Medical Center
- Rockefeller University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.